Jan 05, 2026
FDA Lifts Hold On GH Research’s Depression Drug Trial After Two Years

The U.S. Food and Drug Administration (FDA) on Monday lifted the clinical hold on GH Research Plc’s (NASDAQ:GHRS) Investigational New Drug Application (IND) for GH001. GH Research stock is showing positive momentum. What’s ahead for GHRS stock? “The FDA clearance…

Jan 05, 2026
Samsung Ramps Up AI Strategy, Warns Of Rising Costs

Samsung Electronics Co. Ltd. (OTC:SSNLF) plans to expand the reach of its Galaxy artificial intelligence features, doubling the number of mobile devices powered by AI, intensifying rivalry with Apple Inc. (NASDAQ:AAPL) iPhones. The South Korean tech giant has already rolled…

Jan 05, 2026
Autoliv Debuts World’s First Foldable Steering Wheel

Autoliv, Inc. (NYSE:ALV) and mobility startup Tensor have jointly created a foldable steering wheel for Tensor’s Robocar, designed to free up cabin space and enhance comfort when the vehicle operates autonomously. This wheel functions normally for manual control, then retracts…

Jan 05, 2026
Mobileye Stock Soars On New Deal To Power Hands-Free Driving At Scale

Mobileye Global Inc. (NASDAQ:MBLY) stock rose on Monday after the company announced that a U.S.-based automaker has selected the Mobileye EyeQ6H to enable advanced driver assistance systems with hands-free driving capabilities on select highways across millions of vehicles worldwide. Details…

Jan 05, 2026
KBR Lands $350 Million Federal Contract To Advance Earth Observation

KBR, Inc. (NYSE:KBR) stock rose Monday after the company disclosed that it received a Technical Support Services Contract (TSSC) from the U.S. Geological Survey, with a $350 million ceiling. Details The company will provide advanced technical solutions for the Earth…

Jan 05, 2026
Gallium’s Minor Demand Poses An Outsized Problem

China has paused export restrictions on gallium until November 27, 2026, giving the U.S. time to solve a supply chain problem of this overlooked but vital strategic metal. Gallium is a minor metal by volume but a major enabler of…

Jan 05, 2026
InflaRx Reopens Case For Axed Phase 3 Drug For Rare Skin Disorder

InflaRx N.V. (NASDAQ:IFRX) is reviving hopes for vilobelimab after new analyses showed signs of efficacy in a Phase 3 trial it had previously halted, setting up FDA talks and a potential partner-led path forward. Last Tuesday, the company outlined multiple…

Jan 05, 2026
AMD’s Gamer Boom Signals Trouble For Intel’s Long-Held Lead

Advanced Micro Devices, Inc. (NASDAQ:AMD) is gaining momentum in tandem with improving market share trends and renewed confidence in its artificial intelligence strategy. AMD Gains Ground On Intel Among PC Gamers AMD stock has extended its upward move since Friday,…

Jan 05, 2026
China Strength Fails To Offset Niu’s Global Sales Slowdown

Niu Technologies (NASDAQ:NIU) stock fell on Monday after the company disclosed a decline in sales volumes for the fourth quarter and full year 2025. In the fourth quarter of 2025, the company sold 178,702 units, down from 226,634 units a…